NGL Fine Chem Quarterly Results for Trading Insights
NGLFINE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹10 Cr
QSept 2025
NGL Fine Chem Quarterly Results Key Highlights
- Revenue of ₹122 Cr in Sept 2025 (+29.8% vs Mar 2025, +23.2% vs Sept 2024)
- Net Profit of ₹10 Cr in Sept 2025 (+900.0% vs Mar 2025, +0.0% vs Sept 2024)
- EBITDA of ₹19 Cr in Sept 2025 (+280.0% vs Mar 2025)
- Operating Margin of 14.0% in Sept 2025 (+7.0pp vs Mar 2025)
- Earnings Per Share of ₹15.58 in Sept 2025 (+1670.5% vs Mar 2025)
NGL Fine Chem Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 122 | 94 | 111 | 99 | 103 | 29.8% | 23.2% |
| Net Profit (₹ Cr) | 10 | 1 | 9 | 10 | 12 | - | - |
| EBITDA (₹ Cr) | 19 | 5 | 17 | 17 | 20 | - | - |
| EPS (₹) | 15.58 | 0.88 | 14.96 | 15.88 | 19.95 | - | - |
| Operating Margin (%) | 14.0% | 7.0% | 11.0% | 12.0% | 16.0% | - | - |
NGL Fine Chem Share Price Trend Around Quarterly Results
Visualize NGL Fine Chem's 1-year price movement across quarterly results — ideal for logging trades in NGL Fine Chem share price
chart using Tickjournal. All values in ₹.
Related Pages for NGL Fine Chem
Additional stock information and data for NGLFINE
Revenue Trend (₹ Cr)
Sept 2024
99
Jun 2025
111
Mar 2025
94
Sept 2025
122
Net Profit Trend (₹ Cr)
Sept 2024
10
Jun 2025
9
Mar 2025
1
Sept 2025
10
Operating Margin Trend (%)
Sept 2024
12.0%
Jun 2025
11.0%
Mar 2025
7.0%
Sept 2025
14.0%
Sector Competitors - Quarterly Performance Comparison
Comparing NGL Fine Chem quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹412,613.60 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,570.84 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores